• HOME
  • Search
Original Articles
The Changes of Serum Soluble Intercellular Adhesion Molecule-1(ICAM-1) According to the Clinical Course of Graves' Disease Treated with Antithyroid Drug.
Jin Hong Lee, Jae Kyu Shin, So Young Bak et al.
Endocrinol Metab. 1996;11(3):293-301.   Published online November 7, 2019
Clinical Characteristics of Graves' Disease Patients with Undetectable Thyrotropin Binding Inhibitor Immunoglubulin (TB2).
Bo Youn Cho, Won Bae Kim, Hong Gyu Lee et al.
Endocrinol Metab. 1996;11(1):68-74.   Published online November 7, 2019
The Change of Pulmonary Artery Pressure in Graves'Disease Before and After Treatment.
Taek Man Nam, Han Soo Cho, Jin Seo Lee et al.
Endocrinol Metab. 2003;18(5):465-472.   Published online October 1, 2003
Differential Diagnostic Value of TSH Receptor Antibody Measurements in Thyrotoxic Postpartum Patients with History of Graves' Disease.
Seong Jin Lee, Yun Ey Chung, Ha Young Kim et al.
Endocrinol Metab. 2001;16(1):75-84.   Published online February 1, 2001

and Metabolism

Print ISSN: 2093-596X
Online ISSN: 2093-5978

Editorial Office
101-2503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-716-2428    Fax: +82-2-714-5103    E-mail:                

Copyright © 2022 by Korean Endocrine Society.

Developed in M2PI